INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 417s ago
HOUSE PTR17s ago
SEC 13F29m ago
ROBINHOOD CHAIN29m ago
SEC FORM 4/Open-market saleVerified data

Gao Hanlin sold FLGT

Chief Scientific Officer · Fulgent Genetics, Inc. · Common Stock

Side
SELL
Value
$19K
Shares
939
Price
$19.91
Executed
Aug 27, 2026
Disclosed
Aug 28, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 27 executedAug 28, 2026 disclosed

FLGT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
26/ 100 · ROUTINE
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+1 / 25

    $19K reported value · 0.1% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · FLGT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    26
    XJ
    Xie JianPresident and COO
    FLGTFulgent Genetics, Inc.
    Open-market sale
    		SELL$24K
    1,193 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001684532-26-000009
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 27, 2026
    Published
    Aug 28, 2026
    Ingested by INSIDER
    Nov 5, 02:20 UTC
    Last re-read
    Nov 5, 02:20 UTC

    Extracted facts

    Filer
    Gao Hanlin
    Role
    Chief Scientific Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Fulgent Genetics, Inc.
    Ticker
    FLGT
    Shares
    939
    Price per share
    $19.91
    Value
    $18,691
    Execution date (reported)
    Aug 27, 2026
    Owned after transaction
    987.8K shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 939
    • Price: $19.9053

    = $18,691

    What this establishes

    Gao Hanlin filed this Form 4 reporting a open-market sale of FLGT on Aug 27, 2026. It became public on Aug 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Scientific Officer
    Gao Hanlincik:0001684532
    Issuer
    Fulgent Genetics, Inc.cik:0001674930

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.